Literature DB >> 18728106

Potential aluminum exposure from parenteral nutrition in patients with acute kidney injury.

Rex O Brown1, Laurie M Morgan, Syamal K Bhattacharya, Patti L Johnson, Gayle Minard, Roland N Dickerson.   

Abstract

BACKGROUND: Patients' exposure to and potential toxicity from aluminum in parenteral nutrition (PN) formulations is an important concern of healthcare providers.
OBJECTIVE: To determine the potential for aluminum toxicity caused by PN in hospitalized adults who have risk factors of both acute kidney injury and PN.
METHODS: Adults who required PN and had a serum creatinine (SCr) level at least 1.5 times greater than the admission SCr on the first day of PN were studied in a retrospective fashion. Protein was administered based on whether hemodialysis was being used (0.6-1 g/kg/day without hemodialysis; 1.2-1.5 g/kg/day with hemodialysis). Aluminum exposure was determined for each patient by multiplying the volume of each PN component by its concentration of aluminum. Unpaired t-tests, Fisher's exact test, and analysis of variance were used for statistical analysis. Data are presented as mean +/- SD.
RESULTS: Thirty-six patients (aged 50.4 +/- 20.4 y; weight 90.2 +/- 32.8 kg) were studied. Initial serum urea nitrogen and SCr were 47 +/- 23 and 3.3 +/- 1.4 mg/dL, respectively. Twelve patients received hemodialysis. The mean aluminum exposure was 3.8 +/- 2 microg/kg/day in the 36 patients. Of these, 29 had safe calculated aluminum exposure (<5 microg/kg/day) and 7 had high calculated aluminum exposure (>5 microg/kg/day). Patients with safe aluminum exposure had significantly higher SCr levels than did those with high aluminum exposure (3.5 +/- 1.5 vs 2.2 +/- 0.7 mg/dL; p < 0.04). Patients with high aluminum exposure received significantly more aluminum from calcium gluconate compared with those who had safe aluminum exposure (357 +/- 182 vs 250 +/- 56 microg/day; p < 0.02). Limitations of the study include its retrospective design, which resulted in calculated versus direct measurement of aluminum.
CONCLUSIONS: Using our calculations, we believe that most patients with acute kidney injury who require PN do not receive excessive exposure to aluminum from the PN formulation, despite having 2 risk factors (acute kidney injury, PN) for aluminum toxicity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18728106     DOI: 10.1345/aph.1L061

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  4 in total

1.  The impact of aluminum, fluoride, and aluminum-fluoride complexes in drinking water on chronic kidney disease.

Authors:  Hewa M S Wasana; Gamage D R K Perera; Panduka S De Gunawardena; Jayasundera Bandara
Journal:  Environ Sci Pollut Res Int       Date:  2015-03-20       Impact factor: 4.223

2.  Acute Interstitial Nephritis in a Patient with High Aluminum Blood Levels: A Case Report.

Authors:  Urmila Anandh; Rakesh Kumar Ch; Vikas Aggarwal
Journal:  Indian J Nephrol       Date:  2019-09-06

Review 3.  Layered double hydroxide nanocomposite for drug delivery systems; bio-distribution, toxicity and drug activity enhancement.

Authors:  Aminu Umar Kura; Mohd Zobir Hussein; Sharida Fakurazi; Palanisamy Arulselvan
Journal:  Chem Cent J       Date:  2014-08-10       Impact factor: 4.215

4.  Chelator-Free Labeling of Layered Double Hydroxide Nanoparticles for in Vivo PET Imaging.

Authors:  Sixiang Shi; Brianne C Fliss; Zi Gu; Yian Zhu; Hao Hong; Hector F Valdovinos; Reinier Hernandez; Shreya Goel; Haiming Luo; Feng Chen; Todd E Barnhart; Robert J Nickles; Zhi Ping Xu; Weibo Cai
Journal:  Sci Rep       Date:  2015-11-20       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.